Exosome Protein Engineering Services for CAR-T Persistence Payload

Online Inquiry

Background Service Service Packages Workflow Highlights FAQs Contact

Key hurdles confronting CAR-T therapy encompass T cell exhaustion, limited solid tumor infiltration, and the rapid clearance associated with allogeneic off-the-shelf products. Through our Exosome Protein Engineering for CAR-T Persistence Payloads platform, we overcome these obstacles by leveraging sophisticated surface display and precision cargo loading to deliver persistence-enhancing factors. The resulting engineered exosomes provide CAR-T cells with sustained cytokine support, metabolic modulation, and prolonged circulation. By combining scaffold-based protein engineering, targeted RNA encapsulation, and glycan-based shielding, our approach drives next-generation cell therapies toward greater functional durability, improved resilience within the tumor microenvironment, and an enhanced therapeutic window.

Introduction

Exosome protein engineering integrates glycan-based surface modification with precision cargo loading to generate tailored extracellular vesicles capable of targeted molecular delivery. Applied to CAR-T persistence payloads, this platform enables sustained delivery of durability-enhancing factors that mitigate T cell exhaustion, improve tumor infiltration, and extend therapeutic function.

Fig.1 Protein-engineered exosomes to prolong CAR-T activity. (Creative Biolabs Original) Fig.1 Exosome-based protein engineering for durable CAR-T therapy.

Exosome Protein Engineering for CAR-T Persistence Payloads at Creative Biolabs

Creative Biolabs provides a specialized system for designing exosomes as modular carriers that reinvigorate CAR-T cells in vivo. Through functionalization of the exosomal surface with targeted protein ligands and incorporation of payloads such as glycan-remodeling agents or IL-15 to support homeostatic proliferation, this platform addresses the central challenge of T cell senescence.

Service Packages

**Exosome Scaffold Engineering via Lamp2b & CD63 for CAR-T Cytokines**

This platform focuses on the genetic fusion of therapeutic cytokines to the intraluminal or extracellular domains of exosome-anchoring scaffolds, specifically Lamp2b and CD63. By leveraging these high-density membrane proteins, engineered exosomes display functional cytokines such as IL-7 or IL-15 directly on their surface. This design enables sustained, localized delivery of survival signals to CAR-T cells, effectively replacing systemic cytokine administration with a targeted support mechanism that enhances T cell persistence while minimizing off-target toxicity.

Learn More →

Active Internal Sequestration of CAR-T Potentiating RNA (Exo-Load)

This technology exploits the natural RNA-loading capacity of exosomes to deliver genetic potentiators directly into CAR-T cells. Producer cells are engineered to overexpress specific mRNA or non-coding RNA sequences that are actively sorted into exosomal cargo via endogenous machinery, yielding Exo-Load vesicles. Upon fusion with CAR-T cells, these exosomes deliver regulatory RNA capable of reprogramming cellular metabolism, preventing exhaustion, or sustaining memory phenotypes, thereby providing a non-viral and reversible strategy for dynamically modulating T cell fitness over time.

Learn More →

Surface Glycan Shielding for Extended CAR-T Support Circulation

To address the rapid clearance of therapeutic exosomes by the reticuloendothelial system, this module employs advanced surface glycan engineering. Modification of the exosomal membrane with hyper-sialylated or precisely patterned glycocalyx structures creates a stealth coating that reduces opsonization and phagocytic uptake. This glycan shielding markedly prolongs the circulatory half-life of exosome payloads, ensuring sustained bioavailability for CAR-T support and enabling lower, less frequent dosing regimens while preserving therapeutic efficacy in both peripheral compartments and the tumor microenvironment.

Learn More →

Our Service Process

Required Starting Materials:

Sequence / Plasmid Data: The specific sequence for the persistence payload.
Target Cell Specifications: Detailed profile of lead CAR-T candidate, including surface marker expression and known exhaustion triggers.

Key Steps:

Workflow of CAR-exosome development for cell-free CAR-immunotherapy at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables:

Comprehensive Analytical Report.
Purified, sterile-filtered, and ready-for-use exosomal vehicles.

Key Advantages

Precision Delivery: Engineered exosomes can be surface-modified to achieve targeted delivery, ensuring that persistence-enhancing payloads act specifically on CAR-T cells rather than inducing systemic toxicity.
Self-Enhancing Circuitry: By engineering CAR-T cells to secrete their own supportive exosomes, this strategy establishes an autocrine feedback loop that sustains T-cell survival and function without the need for exogenous administration.
Synergistic Modulation: Exosomes can co-deliver multiple functional molecules, such as homeostatic cytokines, co-stimulatory ligands, and immune checkpoint inhibitors, enabling synergistic preservation of a stem-like memory phenotype and delaying T-cell exhaustion.

FAQs

Q1: What types of payloads can be loaded into the exosomes?

A1: A broad range of functional cargo can be encapsulated, including protein-based therapeutics, immunomodulatory cytokines, messenger RNA, and even CRISPR-Cas9 ribonucleoprotein complexes for transient, targeted genome editing.

Q2: How do you ensure the exosomes target the CAR-T cells specifically?

A2: The exosome surface is functionalized with targeting moieties such as single-chain variable fragments or synthetic ligands that recognize T-cell lineage markers like CD3 or CD8, or alternatively, they can be designed to directly bind the CAR structure itself for enhanced specificity.

Why Choose Us

Our platform leverages precision exosome protein engineering to deliver optimized persistence payloads directly to CAR-T cells. We uniquely combine advanced molecular design with targeted delivery, ensuring sustained effector function, enhanced in vivo durability, and superior therapeutic potential for next-generation cell immunotherapy.

How to contact us?

Creative Biolabs offers an advanced platform for exosome protein engineering designed to deliver persistence payloads for CAR-T therapy. By integrating glycan-based engineering with exosome-mediated delivery, we address key obstacles in CAR-T functional persistence and solid tumor infiltration.

To discuss project details or request a custom proposal, contact our scientific team.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.